The science & prescribing of medicinal cannabis

Three leading integrative medicine bodies will unite in Sydney next month (September 8 – 9) to educate Australian practitioners on the science and prescribing of medicinal cannabis. The 2-day-long, RACGP accredited event will focus on clinical applications, patient safety and local regulations for the prescribing of medicinal cannabis. According to event organisers – the National…

Read More

Simple blood test to detect early stage melanoma on horizon

Aussie researchers have developed the world’s first blood test to detect early stage melanoma. Researchers from Edith Cowan University (ECU), Perth produced the test after examining more than 1,600 functional proteins and identifying 10 auto-antibodies associated with melanoma. Early detection of melanoma is associated with an 80 – 95% survival rate. The blood test, which…

Read More

Pharmaxis granted FDA clearance to produce Aridol locally for US market

ASX-listed pharmaceutical company, Pharmaxis has today been granted FDA clearance to commence Sydney-based production of its asthma diagnostic medication, Aridol for the US. The approval follows hot-on-the-heels of the FDA’s recent inspection of the Sydney facility which manufactures Aridol for Australia, South Korea and Europe, and Bronchitol for Australia, Europe and Russia respectively. Following FDA…

Read More